Importantly, while Keap1 does not significantly collaborate with p53 or Lkb1 loss to accelerate KrasG12D-induced tumorigenesis, all tumor cells harboring Keap1 inactivation exhibit augmented Nrf2 pathway activation. The gene discussed is NFE2L2; the disease is neoplasm.